OneOme

OneOme is a brand that focuses on pharmacogenomics, a branch of precision medicine that explores how genetic variants impact an individual's response to medication. They offer the RightMed Test, a comprehensive pharmacogenomic solution that provides valuable information to healthcare teams about the impact of an individual's DNA on medication-related outcomes. Pharmacogenomics is gaining recognition across various medical specialties, including primary care, psychiatry, and oncology.

With over 5 billion prescriptions filled annually, it's clear that not all drugs are effective for everyone. DNA plays a crucial role in medication response, influencing drug metabolism, mechanism of action, and drug toxicity. OneOme's clinical development process is meticulous, combining scientific and clinical data to optimize medication therapy.

Their database is curated by a team of experienced clinical pharmacists and scientists, ensuring that relationships between medications and pharmacogenes are based on robust scientific evidence. The RightMed Test provides healthcare providers with actionable genetic information to improve patient care. With adverse drug reactions being a leading cause of death in the US, this information holds significant value.

Over 90% of patients possess clinically actionable genetic variants, highlighting the relevance of pharmacogenomics in personalized medicine. With OneOme's expertise and dedication to comprehensive pharmacogenomic solutions, they are at the forefront of revolutionizing patient care and optimizing medication therapy